Sequence Lifescience, Inc.
Clinical trials sponsored by Sequence Lifescience, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Placental grafts show promise for stubborn diabetic foot sores Results expected Jul 2027 (estimated)
-
New hope for bedsores: 2,000-Patient trial tests advanced wound matrices
Disease control Recruiting nowThis study tests whether adding special wound dressings (called CAMPs) to standard care helps heal pressure ulcers (bedsores) that won't close on their own. About 2,000 adults with stage 3 or 4 pressure sores will receive weekly applications of a CAMP product plus standard care, …
Phase 4 • Sponsor: Sequence LifeScience, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Placental grafts show promise for stubborn diabetic foot sores
Disease control Recruiting nowThis study tests whether a special placental graft, used alongside standard wound care, helps close diabetic foot ulcers that won't heal on their own. About 350 adults with type 1 or 2 diabetes and a foot ulcer between 1 and 15 cm² will be randomly assigned to get the graft plus …
Phase 4 • Sponsor: Sequence LifeScience, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC